Vitamin D Supplementation on Cardiovascular Risk Factors

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the present pilot study is to determine the effect of vitamin D supplementation (4000 IU or 6000 IU once daily for 6 months) on reducing heart disease risk and in improving blood glucose control in type 2 Diabetes subjects . The investigators are working with Hispanics and African Americans living in Miami, Florida.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Florida International University
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Type 2 diabetes

• African American or Hispanic

• able to ambulate on their own

• aged between 30 - 70 years

Exclusion Criteria:

• Taking Supplemental Vitamin D

• Pregnant or Lactating women

• Receiving insulin therapy

• Not participating in other drug trials

• HIV/ hepatitis/ cancer/ liver disease/ heart failure/ any recent surgery/ mental illness/ epilepsy/ any GI or malabsorption disorders

• Kidney failure or on dialysis